Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Bone Loss, Osteoclastic

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, M; Inomata, M; Ishibashi, H; Kawashima, S; Koshihara, Y; Saido, TC; Tsubuki, S; Yamamoto, S1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Bone Loss, Osteoclastic

ArticleYear
Involvement of calpain in osteoclastic bone resorption.
    Journal of biochemistry, 2005, Volume: 137, Issue:3

    Topics: Actins; Aged; Bone and Bones; Bone Resorption; Calpain; Cells, Cultured; Dipeptides; Humans; Leucine; Osteoclasts; Recombinant Fusion Proteins; Talin

2005